Thanks for sharing your research. If their test can predict prostate Ca in situ, with no metastasis, then that’s huge! Imagine the implications for treatment! Women suffer, but it’s men that suffer more later in life & retirement years, when they should be enjoying the fruits of their labour.
See this announcement as a positive (as did the ASX as price sensitive).
We eagerly await news from USA & Mexico on PromarkerD for DKD.
DXB ASX (Dimerix) have begun recruiting at 2 trial sites, with a further 8 trial sites in Australia, & will be utilising PromarkerD in clinical trials. We don’t know how. So just an update there for all on PIQ from co-joined investors lol.
GLTA
PIQ Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)